ezogabine has been researched along with methylphenidate in 1 studies
| Studies (ezogabine) | Trials (ezogabine) | Recent Studies (post-2010) (ezogabine) | Studies (methylphenidate) | Trials (methylphenidate) | Recent Studies (post-2010) (methylphenidate) |
|---|---|---|---|---|---|
| 383 | 26 | 241 | 7,783 | 1,698 | 2,693 |
| Protein | Taxonomy | ezogabine (IC50) | methylphenidate (IC50) |
|---|---|---|---|
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.061 | |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.083 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 5.1 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.079 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreasen, JT; Hansen, HH; Mikkelsen, JD; Mirza, N; Scheel-Krüger, J; Weikop, P | 1 |
1 other study(ies) available for ezogabine and methylphenidate
| Article | Year |
|---|---|
The neuronal KCNQ channel opener retigabine inhibits locomotor activity and reduces forebrain excitatory responses to the psychostimulants cocaine, methylphenidate and phencyclidine.
Topics: Animals; Carbamates; Central Nervous System Stimulants; Cocaine; Dopamine; Excitatory Amino Acid Antagonists; KCNQ Potassium Channels; Male; Membrane Transport Modulators; Methylphenidate; Motor Activity; Phencyclidine; Phenylenediamines; Prosencephalon; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 2007 |